1. Home
  2. OWLT vs CLLS Comparison

OWLT vs CLLS Comparison

Compare OWLT & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Owlet Inc.

OWLT

Owlet Inc.

HOLD

Current Price

$5.66

Market Cap

144.7M

Sector

Health Care

ML Signal

HOLD

Logo Cellectis S.A.

CLLS

Cellectis S.A.

HOLD

Current Price

$4.09

Market Cap

384.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OWLT
CLLS
Founded
2013
1999
Country
United States
France
Employees
114
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.7M
384.3M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
OWLT
CLLS
Price
$5.66
$4.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$17.50
$8.33
AVG Volume (30 Days)
281.4K
37.9K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$22.89
N/A
Revenue Next Year
$21.22
$0.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.09
$1.33
52 Week High
$16.94
$5.48

Technical Indicators

Market Signals
Indicator
OWLT
CLLS
Relative Strength Index (RSI) 42.70 63.19
Support Level $4.19 $3.25
Resistance Level $9.17 $4.46
Average True Range (ATR) 0.38 0.22
MACD 0.30 0.12
Stochastic Oscillator 100.00 71.16

Price Performance

Historical Comparison
OWLT
CLLS

About OWLT Owlet Inc.

Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: